Industry watch
What the SEC, the accounting standard-setters, and the biotech trade press published that a controller or CFO at a life-sciences company should see. Selected automatically, ranked by relevance and recency.
The Public Company Accounting Oversight Board (PCAOB) on November 3, 2026, voted unanimously to issue a proposal that would change …
Stakeholders have until Jan. 4 to comment on a proposal to simplify the application of guidance used to determine whether equity-linked contracts, such as warrants, should be considered indexed to an entity's own stock…
For most biopharmas, guiding to flat growth for the year would be a disappointment. For Novo, it’s an upgrade. The drugmaker said Wednesday that its 2026 sales would be between 2% ...
A Chinese biotech is selling the Japanese rights for its Phase 3 thyroid eye disease drug to a 106-year-old specialty pharma long known for its thyroid hormone business. Shanghai-based Minghui Pharmaceutical will ...
Rose BioSolutions CEO David Enloe argues that advanced therapies demand deeper scientific collaboration, earlier problem-solving, and shared accountability
Much of the US financial reporting rulebook will continue to be applicable should the SEC adjust how often public companies need to file financial reports, accounting board staff said Thursday.
Sanders could use his role in crafting the FDA funding bill to push for reforms.
The biopharma industry was already on pace for one China deal per week for the entire year. Now, another two biotechs have snagged assets from the world's busiest shopping mall for new ...
The board’s review of 2025 public company audit inspections revealed a significant decrease from 2024 in instances where an audit firm failed to obtain sufficient appropriate evidence to support its opinion on a…
Stakeholders have until Jan. 11 to provide feedback on a proposed Accounting Standard Update aimed at improving operability and reducing complexity and cost.
Abdul El-Sayed, the Democratic Senate candidate in Michigan, pushes back against the RFK Jr.'s claims, and the new FDA policy around peptides.
By the end of Q3, the Denmark-based pharmaceutical company said it had rolled out the pill form of its weight-loss drug in eight countries.
The amended rules align with efforts by SEC Chair Paul Atkins to streamline compliance and promote regulation that is “grounded in First Principles.”
The New York City-based pharmaceutical giant appointed Cecile Guegan to succeed former CFO Dave Denton. She took the new position Sunday.
In this Point of View Sun Chau Siu, PhD, and Kaisong Zhou, PhD, give insights on the hidden challenges of transferring intellectual property.
The startup is working on a medicine one of its investors claimed could have a broader reach than other approved drugs for a group of conditions known as myeloproliferative neoplasms.
Anthropic is setting the stage for the largest IPO in history and Akeso has been touting its latest positive results for its buzzy bispecific.
The Securities and Exchange Commission’s Small Business Capital Formation Advisory Committee announced that it will hold a meeting on Tuesday, October 27, 2026, at 10 a.m. to continue discussing IPO modernization and…
The drug’s third-quarter sales numbers came in well above consensus estimates, widening Novo’s early edge over Eli Lilly in the latest battleground for weight loss medicines.
Novo won't launch its big obesity hope CagriSema in Europe for another “couple of years,” Novo’s outgoing CFO Karsten Munk Knudsen told Endpoints News in a Wednesday interview. “For CagriSema, the clear ...
The Securities and Exchange Commission’s Division of Economic and Risk Analysis (DERA) published updated statistics and data visualizations covering key segments of the U.S. capital markets, including a notable increase…
The Securities and Exchange Commission today charged private fund adviser Meyer Global Management LLC (MGM) and its CEO, Owen E.H. Meyer, with defrauding investors and MGM-managed funds in connection with investments in…
That’s the latest
You’re all caught up.
Updated Nov 5, 4:00 PM EST. New headlines are added as the feeds publish, and this list refreshes hourly.
Sources include SEC, Journal of Accountancy, Accounting Today, Bloomberg Tax, CFO Dive, CFO.com, Thomson Reuters Tax, AccountingWEB, CPA Practice Advisor, Endpoints News, Fierce Biotech, BioPharma Dive, STAT, GEN, PharmaVoice, LifeSciVC, plus targeted searches of the wider press. Headlines are chosen by an automated relevance filter, not by editorial review, and link to the original publisher. Inclusion is not an endorsement, and nothing here is accounting, tax, or investment advice.